Selank 10mg

Description

Selank 10mg is supplied as lyophilized powder with a labeled amount of 10mg per vial, for in-vitro laboratory research only.

Selank is a synthetic peptide studied in neuropeptide research. This listing identifies the standalone Selank product and provides analytical documentation for its current batch.

Product specifications

• Peptide: Selank
• Label amount: 10mg per vial
• Form: lyophilized powder
• Product format: standalone Selank research material

The 10mg label amount identifies this product; it is not a concentration in mg/mL. Measured analytical results are reported separately for the tested batch.

Current batch and analytical results

BT Labs report COA261200-005 documents batch CP-SEL-2608. The sample was tested on 28 August 2026; the report is dated 2 September 2026.

• Identity: FTIR confirms the presence of Selank with excipients/fillers.
• HPLC purity: 99.7%
• HPLC potency: 12.6 mg

These results apply to the tested sample from this batch and are not guarantees for every vial or future batch. Identity, purity and potency testing do not establish sterility or endotoxin status.

Read the Selank batch CP-SEL-2608 COA summary (page 1 of a two-page report). Use the batch number on your product documentation to find the matching record in Currently Shipping COAs or the Batch Ledger.

Selank research information

For educational context, see the Selank research overview. Research background does not establish benefits or suitability for human or veterinary use.

Standalone product and related blend

This page is for standalone Selank with a 10mg label amount. The separate Semax + Selank 10mg + 10mg blend contains 10mg of each peptide, or 20mg combined. Its batch documentation is separate from this product’s COA. Standalone Semax 10mg is also available.

Research use only

For laboratory research only. Not for human or veterinary use, diagnosis or treatment. See the research-use-only information.